Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Activation-induced cell death of self-reactive regulatory T cells drives autoimmunity.

Badami E, Cexus ONF, Quaratino S.

Proc Natl Acad Sci U S A. 2019 Dec 9. pii: 201910281. doi: 10.1073/pnas.1910281116. [Epub ahead of print]

PMID:
31818938
2.

Prospects for combining targeted and conventional cancer therapy with immunotherapy.

Gotwals P, Cameron S, Cipolletta D, Cremasco V, Crystal A, Hewes B, Mueller B, Quaratino S, Sabatos-Peyton C, Petruzzelli L, Engelman JA, Dranoff G.

Nat Rev Cancer. 2017 May;17(5):286-301. doi: 10.1038/nrc.2017.17. Epub 2017 Mar 24. Review.

PMID:
28338065
3.

miR-19-Mediated Inhibition of Transglutaminase-2 Leads to Enhanced Invasion and Metastasis in Colorectal Cancer.

Cellura D, Pickard K, Quaratino S, Parker H, Strefford JC, Thomas GJ, Mitter R, Mirnezami AH, Peake NJ.

Mol Cancer Res. 2015 Jul;13(7):1095-1105. doi: 10.1158/1541-7786.MCR-14-0466. Epub 2015 May 1.

4.

NHS-IL2 combined with radiotherapy: preclinical rationale and phase Ib trial results in metastatic non-small cell lung cancer following first-line chemotherapy.

van den Heuvel MM, Verheij M, Boshuizen R, Belderbos J, Dingemans AM, De Ruysscher D, Laurent J, Tighe R, Haanen J, Quaratino S.

J Transl Med. 2015 Jan 27;13:32. doi: 10.1186/s12967-015-0397-0.

5.

New Approaches in Immunotherapy for the Treatment of Lung Cancer.

Quaratino S, Forssmann U, Marschner JP.

Curr Top Microbiol Immunol. 2017;405:1-31. doi: 10.1007/82_2014_428. Review.

PMID:
25522903
6.

Abituzumab combined with cetuximab plus irinotecan versus cetuximab plus irinotecan alone for patients with KRAS wild-type metastatic colorectal cancer: the randomised phase I/II POSEIDON trial.

Élez E, Kocáková I, Höhler T, Martens UM, Bokemeyer C, Van Cutsem E, Melichar B, Smakal M, Csőszi T, Topuzov E, Orlova R, Tjulandin S, Rivera F, Straub J, Bruns R, Quaratino S, Tabernero J.

Ann Oncol. 2015 Jan;26(1):132-40. doi: 10.1093/annonc/mdu474. Epub 2014 Oct 15.

7.

Innate and adaptive immune responses to the major Parietaria allergen Par j 1 in healthy subjects.

Bonura A, Quaratino S, Gervasi F, Melis MR, Di Sano C, Colombo P.

Immunobiology. 2013 Jul;218(7):995-1004. doi: 10.1016/j.imbio.2012.11.006. Epub 2012 Nov 30.

PMID:
23332216
8.

T-cell activation by treatment of cancer patients with EMD 521873 (Selectikine), an IL-2/anti-DNA fusion protein.

Laurent J, Touvrey C, Gillessen S, Joffraud M, Vicari M, Bertrand C, Ongarello S, Liedert B, Gallerani E, Beck J, Omlin A, Sessa C, Quaratino S, Stupp R, Gnad-Vogt US, Speiser DE.

J Transl Med. 2013 Jan 7;11:5. doi: 10.1186/1479-5876-11-5.

9.

Defective CFTR induces aggresome formation and lung inflammation in cystic fibrosis through ROS-mediated autophagy inhibition.

Luciani A, Villella VR, Esposito S, Brunetti-Pierri N, Medina D, Settembre C, Gavina M, Pulze L, Giardino I, Pettoello-Mantovani M, D'Apolito M, Guido S, Masliah E, Spencer B, Quaratino S, Raia V, Ballabio A, Maiuri L.

Nat Cell Biol. 2010 Sep;12(9):863-75. doi: 10.1038/ncb2090. Epub 2010 Aug 15.

PMID:
20711182
10.

Lysosomal accumulation of gliadin p31-43 peptide induces oxidative stress and tissue transglutaminase-mediated PPARgamma downregulation in intestinal epithelial cells and coeliac mucosa.

Luciani A, Villella VR, Vasaturo A, Giardino I, Pettoello-Mantovani M, Guido S, Cexus ON, Peake N, Londei M, Quaratino S, Maiuri L.

Gut. 2010 Mar;59(3):311-9. doi: 10.1136/gut.2009.183608. Epub 2009 Dec 1. Erratum in: Gut. 2010 Jul;59(7):1007.

PMID:
19951908
11.

SUMOylation of tissue transglutaminase as link between oxidative stress and inflammation.

Luciani A, Villella VR, Vasaturo A, Giardino I, Raia V, Pettoello-Mantovani M, D'Apolito M, Guido S, Leal T, Quaratino S, Maiuri L.

J Immunol. 2009 Aug 15;183(4):2775-84. doi: 10.4049/jimmunol.0900993. Epub 2009 Jul 22. Erratum in: J Immunol. 2014 Nov 15;193(10):5347-9.

12.

Tissue transglutaminase activation modulates inflammation in cystic fibrosis via PPARgamma down-regulation.

Maiuri L, Luciani A, Giardino I, Raia V, Villella VR, D'Apolito M, Pettoello-Mantovani M, Guido S, Ciacci C, Cimmino M, Cexus ON, Londei M, Quaratino S.

J Immunol. 2008 Jun 1;180(11):7697-705.

13.

Anti tumour necrosis-alpha therapy increases the number of FOXP3 regulatory T cells in children affected by Crohn's disease.

Ricciardelli I, Lindley KJ, Londei M, Quaratino S.

Immunology. 2008 Oct;125(2):178-83. doi: 10.1111/j.1365-2567.2008.02839.x. Epub 2008 Apr 16.

14.

Unexpected role of surface transglutaminase type II in celiac disease.

Maiuri L, Ciacci C, Ricciardelli I, Vacca L, Raia V, Rispo A, Griffin M, Issekutz T, Quaratino S, Londei M.

Gastroenterology. 2005 Nov;129(5):1400-13.

PMID:
16285941
15.

A search for the holy grail: non-toxic gluten for celiac patients.

Londei M, Maiuri L, Quaratino S.

Gastroenterology. 2005 Sep;129(3):1111-3. No abstract available.

PMID:
16143146
16.

Inhibition of p38 mitogen activated protein kinase controls airway inflammation in cystic fibrosis.

Raia V, Maiuri L, Ciacci C, Ricciardelli I, Vacca L, Auricchio S, Cimmino M, Cavaliere M, Nardone M, Cesaro A, Malcolm J, Quaratino S, Londei M.

Thorax. 2005 Sep;60(9):773-80. Epub 2005 Jun 30.

17.
18.

Gliadin as a stimulator of innate responses in celiac disease.

Londei M, Ciacci C, Ricciardelli I, Vacca L, Quaratino S, Maiuri L.

Mol Immunol. 2005 May;42(8):913-8. Epub 2005 Jan 11. Review.

PMID:
15829281
19.

Protein conformation significantly influences immune responses to prion protein.

Khalili-Shirazi A, Quaratino S, Londei M, Summers L, Tayebi M, Clarke AR, Hawke SH, Jackson GS, Collinge J.

J Immunol. 2005 Mar 15;174(6):3256-63.

20.

Human autoantibodies modulate the T cell epitope repertoire but fail to unmask a pathogenic cryptic epitope.

Quaratino S, Ruf J, Osman M, Guo J, McLachlan S, Rapoport B, Londei M.

J Immunol. 2005 Jan 1;174(1):557-63.

21.

Degenerate self-reactive human T-cell receptor causes spontaneous autoimmune disease in mice.

Quaratino S, Badami E, Pang YY, Bartok I, Dyson J, Kioussis D, Londei M, Maiuri L.

Nat Med. 2004 Sep;10(9):920-6. Epub 2004 Aug 15.

PMID:
15311276
22.

Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease.

Maiuri L, Ciacci C, Ricciardelli I, Vacca L, Raia V, Auricchio S, Picard J, Osman M, Quaratino S, Londei M.

Lancet. 2003 Jul 5;362(9377):30-7.

PMID:
12853196
23.

Celiac disease: a model autoimmune disease with gene therapy applications.

Londei M, Quaratino S, Maiuri L.

Gene Ther. 2003 May;10(10):835-43. Review.

PMID:
12732869
25.

IL-15 drives the specific migration of CD94+ and TCR-gammadelta+ intraepithelial lymphocytes in organ cultures of treated celiac patients.

Maiuri L, Ciacci C, Vacca L, Ricciardelli I, Auricchio S, Quaratino S, Londei M.

Am J Gastroenterol. 2001 Jan;96(1):150-6.

PMID:
11197245
26.

FAS engagement drives apoptosis of enterocytes of coeliac patients.

Maiuri L, Ciacci C, Raia V, Vacca L, Ricciardelli I, Raimondi F, Auricchio S, Quaratino S, Londei M.

Gut. 2001 Mar;48(3):418-24.

27.

Interleukin 15 mediates epithelial changes in celiac disease.

Maiuri L, Ciacci C, Auricchio S, Brown V, Quaratino S, Londei M.

Gastroenterology. 2000 Oct;119(4):996-1006.

PMID:
11040186
28.

Fully competent dendritic cells as inducers of T cell anergy in autoimmunity.

Quaratino S, Duddy LP, Londei M.

Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):10911-6.

29.

Blockage of T-cell costimulation inhibits T-cell action in celiac disease.

Maiuri L, Auricchio S, Coletta S, De Marco G, Picarelli A, Di Tola M, Quaratino S, Londei M.

Gastroenterology. 1998 Sep;115(3):564-72.

PMID:
9721153
30.

A self-peptide with poor stimulatory activity induces T cell tolerance in a self-reactive human T cell clone.

Quaratino S, Londei M.

Biochem Soc Trans. 1997 May;25(2):309S. No abstract available.

PMID:
9191353
31.
32.

Autoantibody-mediated capture and presentation of autoantigen to T cells via the Fc epsilon receptor by a recombinant human autoantibody Fab converted to IgE.

Guo J, Quaratino S, Jaume JC, Costante G, Londei M, McLachlan SM, Rapoport B.

J Immunol Methods. 1996 Sep 9;195(1-2):81-92.

PMID:
8814323
33.
34.

Similar antigenic surfaces, rather than sequence homology, dictate T-cell epitope molecular mimicry.

Quaratino S, Thorpe CJ, Travers PJ, Londei M.

Proc Natl Acad Sci U S A. 1995 Oct 24;92(22):10398-402.

35.

Human autoreactive T-cell clones show flexibility in recognizing overlapping microepitopes, but inflexibility in T-cell receptor usage.

Londei M, Dayan C, Feldmann M, Acuto O, Quaratino S.

Ann N Y Acad Sci. 1995 Jul 7;756:345-8. No abstract available.

PMID:
7645850
36.

Comparison of peptide and superantigen-induced anergy in a peptide-specific polyclonal human T cell line.

Chu NR, Quaratino S, Feldmann M, Londei M.

Int Immunol. 1995 Jul;7(7):1057-63.

PMID:
8527403
37.

Definition of unique traits of human CD4-CD8- alpha beta T cells.

Murison JG, Quaratino S, Kahan M, Verhoef A, Londei M.

Clin Exp Immunol. 1993 Sep;93(3):464-70.

39.

Human CD4- CD8- alpha beta+ T cells express a functional T cell receptor and can be activated by superantigens.

Quaratino S, Murison G, Knyba RE, Verhoef A, Londei M.

J Immunol. 1991 Nov 15;147(10):3319-23.

PMID:
1658144
40.

Phenotypic and functional heterogeneity of double negative (CD4-CD8-) alpha beta TcR+ T cell clones.

Murison JG, Quaratino S, Londei M.

Curr Top Microbiol Immunol. 1991;173:215-20. No abstract available.

PMID:
1833146
41.

Double-stranded RNA excess in hematologic diseases: clinical implications.

Musso M, Abbadessa V, Perricone R, Di Miceli F, Quaratino S, Di Caro A, Cajozzo A.

Haematologica. 1989 Jan-Feb;74(1):5-9.

PMID:
2498183
42.

Plasma exchange for the management of cyclosporin A-induced hypertriglyceridemia.

Valbonesi M, Occhini D, Capra C, Frisoni R, Fella M, Quaratino S, Pittaluga PA.

Int J Artif Organs. 1988 May;11(3):209-11.

PMID:
3042634
43.

Thrombotic microangiopathy of the miscellaneous secondary type responding to plasma exchange in a liver transplant recipient.

Valbonesi M, Valente U, Pellicci R, Piri C, Ferrari M, Frisoni R, Zia S, Quaratino S, Fella M.

Int J Artif Organs. 1988 Mar;11(2):131-3.

PMID:
3286527

Supplemental Content

Loading ...
Support Center